SynBioBeta Speaker

Clayton Rabideau

CEO

Syntensor Incorporated

YEAR

25

May 2025, SynBioBeta

Speaker

Clayton is the founder of Syntensor, a startup that develops frontier models for drug development and human genetics with a particular focus on predicting the underlying drivers of clinical trial outcomes and trait prediction from human genomes."

SynBioBeta 2025 - Keynote

Reprogramming Biology at Cloud Speed

Biotech is accelerating—and cloud infrastructure is the catalyst. This session explores how scalable compute, AI-native architectures, and real-time data integration are transforming the way biology is engineered. From protein design to genome editing, discover how innovators are leveraging cloud-native platforms to run complex simulations, automate workflows, and shorten the cycle from hypothesis to insight. Hear from leaders building the tools that are making biology programmable, iterative, and as fast as software development.

AI-Driven Breakthroughs: Accelerating Drug Discovery and Genetic Medicine

In an era where AI is transforming medicine, drug discovery and genetic therapies are entering a new frontier. This session will explore how AI accelerates the development of innovative therapies, from optimizing molecular designs to enabling precise, tissue-specific genetic interventions. Discover how cutting-edge AI technologies are advancing therapeutic modalities, enhancing delivery systems, and unlocking the potential of personalized medicine. Join leading experts as they share groundbreaking insights into AI-driven innovation and its profound impact on the future of drug discovery and genetic medicine.

AI-Driven Insights: Predicting Efficacy and Toxicity in Next-Gen Drug Discovery

AI is revolutionizing drug discovery—not just by accelerating timelines, but by enhancing our ability to predict how drugs behave in the body. This session highlights cutting-edge approaches like dynamic systems simulations that model mechanistic interactions at the cellular level. Learn how platforms are able to generating causal hypotheses to forecast both efficacy and toxicity, unlocking smarter, safer therapeutic development.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

Previous Speakers Include

Sign Up
Sign Up